Drug Type Contrast agent, Small molecule drug |
Synonyms Pegylated Iron Oxide Nanoparticles (MegaPro Biomed), MPB 1523, MPB1523 |
Target- |
Action enhancers |
Mechanism Magnetic resonance imaging enhancers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Phase 2 | Taiwan Province | 22 Nov 2018 |